BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 12721556)

  • 1. Europe sees sharp decline in GMO research.
    Mitchell P
    Nat Biotechnol; 2003 May; 21(5):468-9. PubMed ID: 12721556
    [No Abstract]   [Full Text] [Related]  

  • 2. Italy employs further GMO delay tactics.
    Meldolesi A
    Nat Biotechnol; 2003 Apr; 21(4):346. PubMed ID: 12665808
    [No Abstract]   [Full Text] [Related]  

  • 3. Orphans at the window.
    Nat Biotechnol; 2004 Sep; 22(9):1055. PubMed ID: 15340451
    [No Abstract]   [Full Text] [Related]  

  • 4. No Munich on GM crops.
    Malvoisin P; Grausz JD
    Nat Biotechnol; 2004 Dec; 22(12):1501; discussion 1501. PubMed ID: 15583648
    [No Abstract]   [Full Text] [Related]  

  • 5. Recipe for disaster.
    Nat Biotechnol; 2003 May; 21(5):465. PubMed ID: 12721554
    [No Abstract]   [Full Text] [Related]  

  • 6. Who is driving biotechnology acceptance?
    Kalaitzandonakes N; Bijman J
    Nat Biotechnol; 2003 Apr; 21(4):366-9. PubMed ID: 12665818
    [No Abstract]   [Full Text] [Related]  

  • 7. Clone on the range: What animal biotech is bringing to the table.
    Dove AW
    Nat Biotechnol; 2005 Mar; 23(3):283-5. PubMed ID: 15765075
    [No Abstract]   [Full Text] [Related]  

  • 8. The science and politics of plant biotechnology--a personal perspective.
    Vasil IK
    Nat Biotechnol; 2003 Aug; 21(8):849-51. PubMed ID: 12894193
    [No Abstract]   [Full Text] [Related]  

  • 9. Agricultural biotech: the rice squad.
    Surridge C
    Nature; 2002 Apr; 416(6881):576-8. PubMed ID: 11948321
    [No Abstract]   [Full Text] [Related]  

  • 10. Acceptance of golden rice in the Philippine 'rice bowl'.
    Chong M
    Nat Biotechnol; 2003 Sep; 21(9):971-2. PubMed ID: 12949549
    [No Abstract]   [Full Text] [Related]  

  • 11. Putting Cartagena into practice.
    Watanabe KN; Taeb M; Okusu H
    Nat Biotechnol; 2004 Oct; 22(10):1207-8. PubMed ID: 15470448
    [No Abstract]   [Full Text] [Related]  

  • 12. Rethinking US leadership in food biotechnology.
    Taylor MR
    Nat Biotechnol; 2003 Aug; 21(8):852-4. PubMed ID: 12894194
    [No Abstract]   [Full Text] [Related]  

  • 13. European agbiotech crisis?
    Fenning TM; Gershenzon J
    Nat Biotechnol; 2003 Apr; 21(4):360. PubMed ID: 12665816
    [No Abstract]   [Full Text] [Related]  

  • 14. Food: Inside the hothouses of industry.
    Gilbert N
    Nature; 2010 Jul; 466(7306):548-51. PubMed ID: 20671688
    [No Abstract]   [Full Text] [Related]  

  • 15. The difficulty of structuring and focusing the co-existence debate in Europe.
    Custers R
    Biotechnol J; 2007 Sep; 2(9):1086-7. PubMed ID: 17703493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Another inconvenient truth. In Europe, no one apparently wants to listen if you have good news about genetically modified organisms (GMOs).
    Nat Biotechnol; 2007 Dec; 25(12):1330. PubMed ID: 18066008
    [No Abstract]   [Full Text] [Related]  

  • 17. Parallel biopolitical universes.
    Morris SH
    Nat Biotechnol; 2007 Jan; 25(1):33-4. PubMed ID: 17211389
    [No Abstract]   [Full Text] [Related]  

  • 18. Plant biotechnology.
    Molina A
    Curr Opin Biotechnol; 2010 Apr; 21(2):182-4. PubMed ID: 20347290
    [No Abstract]   [Full Text] [Related]  

  • 19. Transparent communication strategy on GMOs: will it change public opinion?
    Sinemus K; Egelhofer M
    Biotechnol J; 2007 Sep; 2(9):1141-6. PubMed ID: 17703492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trials, tribulations and diversification.
    Nat Biotechnol; 2003 Dec; 21(12):1411. PubMed ID: 14647307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.